Q-NiFlex™ – Multi-Target Joint Support Formulation Powered by QuanticSphere™
Q-NiFlex™ is a multi-ingredient joint support nutraceutical formulated using QuanticSphere™ (PQNS) phospholipid nano-delivery technology.
The formulation integrates a broad matrix of structural, anti-inflammatory, antioxidant, and supportive actives designed to address key aspects of joint function, mobility, and long-term musculoskeletal support.
QuanticSphere™ PQNS technology is applied to enhance the absorption, stability, and controlled release of traditionally low-bioavailability ingredients. This enables improved systemic exposure at lower doses while supporting gastrointestinal tolerance.
Q-NiFlex™ is developed for nutraceutical and preventive health applications and is manufactured under WHO-GMP and ISO-certified quality systems, with scalability for global markets.
Crassula Pharmaceuticals
-
Country/Region:United States
-
On CPHI since:2023
-
Certificates:2
-
Employees:500 - 999
Other Content from Crassula Pharmaceuticals (1)
-
News Launch of QuanticSphere™ (PQNS) – Advanced Phospholipid Nano-Delivery Platform
Crassula Pharmaceuticals announces the launch of QuanticSphere™ (PQNS), a proprietary phospholipid-based nano-delivery technology designed to improve the bioavailability, stability, and controlled release of nutraceutical and functional ingredients. The platform addresses absorption limitations commonly associated with lipophilic and poorly soluble actives and is available for ingredient and CDMO applications.